Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field

Physics in Medicine and Biology

Volumn 57, Issue 19, 2012, Pages 6047-6061

  Paganetti, Harald ^a   Athar, Basit S ^a   Moteabbed, Maryam ^a   A Adams, Judith ^a   Schneider, Uwe ^b,c   Yock, Torunn I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Hirslanden Medical Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEAM PATH; CANCER RISK; EWING'S SARCOMA; HIGH DOSE; IN-FIELD; PEDIATRIC PATIENTS; PRIMARY RADIATIONS; PROTON THERAPY; RADIATION-INDUCED; REPOPULATION; RISK MODEL; SECOND MALIGNANCY; SOFT TISSUE; SOFT TISSUE SARCOMA; TOTAL DOSE; TOTAL ENERGY; TREATMENT PLANNING; TREATMENT PLANNING SYSTEMS; TREATMENT PLANS; TUMOR VOLUMES; VERTEBRAL BODY; WHOLE-BODY PHANTOMS;

PATIENT MONITORING; PROTON BEAMS; RADIOTHERAPY; RISK ASSESSMENT; RISK PERCEPTION; TUMORS;

PHYSICAL THERAPY;

ADOLESCENT; ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; EWING SARCOMA; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; OPTIC NERVE GLIOMA; ORGANS AT RISK; PRESCHOOL CHILD; PROTON THERAPY; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; RADIATION SCATTERING; RISK ASSESSMENT;

ADOLESCENT; CHILD, PRESCHOOL; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; NEOPLASMS, RADIATION-INDUCED; OPTIC NERVE GLIOMA; ORGANS AT RISK; PROTON THERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SARCOMA, EWING; SCATTERING, RADIATION;

EID: 84866318156     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/57/19/6047     Document Type: Article

References (63)

1. Anderson R N and DeTurk P B 2002 United states life tables Natl Vital Stat. Rep. 50 1-12
2. Armstrong G T, Liu W, Leisenring W, Yasui Y, Hammond S, Bhatia S, Neglia J P, Stovall M, Srivastava D and Robison L L 2011 Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study J. Clin. Oncol. 29 3056-64
3. Athar B S, Bednarz B, Seco J, Hancox C and Paganetti H 2010 Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients Phys. Med. Biol. 55 2879-92
4. Athar B S and Paganetti H 2009 Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy Phys. Med. Biol. 54 4907-26
5. Athar B S and Paganetti H 2011 Comparison of the risk for developing a second cancer due to out-of-field doses after 6 MV IMRT and proton therapy Radiother. Oncol. 98 87-92
6. Bacci G, Longhi A, Barbieri E, Ferrari S, Mercuri M, Briccoli A, Versari M, Pignotti E and Picci P 2005 Second malignancy in 597 patients with Ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999 J. Pediatr. Hematol. Oncol. 27 517-20
7. Bassal M et al 2006 Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the childhood cancer survivor study J. Clin. Oncol. 24 476-83
8. BEIR 2006 Health Risks From Exposure to Low Levels of Ionizing Radiation BEIR VII Phase 2 (Washington DC: National Research Council, National Academy of Science)
9. Bhatia S and Landier W 2005 Evaluating survivors of pediatric cancer Cancer J. 11 340-54
10. Brenner D J and Hall E J 2008 Secondary neutrons in clinical proton radiotherapy: a charged issue Radiother. Oncol. 86 165-70
11. Brown A P, Fixsen J A and Plowman P N 1987 Local control of Ewing's sarcoma: an analysis of 67 patients Br. J. Radiol. 60 261-8
12. Dasu A and Toma-Dasu I 2005 Dose-effect models for risk-relationship to cell survival parameters Acta Oncol. 44 829-35
13. Diallo I et al 2009 Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer Int. J. Radiat. Oncol. Biol. Phys. 74 876-83
14. Dunst J, Ahrens S, Paulussen M, Rube C, Winkelmann W, Zoubek A, Harms D and Jurgens H 1998 Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies Int. J. Radiat. Oncol. Biol. Phys. 42 379-84
15. Epstein R, Hanham I and Dale R 1997 Radiotherapy-induced second cancers: Are we doing enough to protect young patients? Eur. J. Cancer 33 526-30
16. Fontenot J D, Bloch C, Followill D, Titt U and Newhauser W D 2010 Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy Phys. Med. Biol. 55 6987-98
17. Foss Abrahamsen A, Andersen A, Nome O, Jacobsen A B, Holte H, Foss Abrahamsen J and Kvaloy S 2002 Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time Ann. Oncol. 13 1786-91
18. Fowler J 1989 The linear-quadratic formula and progress in fractionated radiotherapy Br. J. Radiol. 62 679-94
19. Fuss M, Hug E B, Schaefer R A, Nevinny-Stickel M, Miller D W, Slater J M and Slater J D 1999 Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique Int. J. Radiat. Oncol. Biol. Phys. 45 1117-26
20. Imaizumi M et al 2006 Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure JAMA 295 1011-22
21. Kenney L B, Yasui Y, Inskip P D, Hammond S, Neglia J P, Mertens A C, Meadows A T, Friedman D, Robison L L and Diller L 2004 Breast cancer after childhood cancer: a report from the childhood cancer survivor study Ann. Intern. Med. 141 590-7
22. Kuttesch J F Jr et al 1996 Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas J. Clin. Oncol. 14 2818-25
23. Lindsay K A, Wheldon E G, Deehan C and Wheldon T E 2001 Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy Br. J. Radiol. 74 529-36
24. Lomax A J, Bortfeld T, Goitein G, Debus J, Dykstra C, Tercier P-A, Coucke P A and Mirimanoff R O 1999 A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy Radiother. Oncol. 51 257-71
25. Marcus R B Jr, Cantor A, Heare T C, Graham-Pole J, Mendenhall N P and Million R R 1991 Local control and function after twice-a-day radiotherapy for Ewing's sarcoma of bone Int. J. Radiat. Oncol. Biol. Phys. 21 1509-15
26. McLean T W, Hertel C, Young M L, Marcus K, Schizer M A, Gebhardt M, Weinstein H J, Perez-Atayde A and Grier H E 1999 Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber cancer institute/children's hospital experience J. Pediatr. Hematol. Oncol. 21 486-93
27. Merchant T E, Hua C H, Shukla H, Ying X, Nill S and Oelfke U 2008 Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function Pediatr. Blood Cancer 51 110-7
28. Miralbell R, Lomax A, Cella L and Schneider U 2002 Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors Int. J. Radiat. Oncol. Biol. Phys. 54 824-9
29. Navid F, Billups C, Liu T, Krasin M J and Rodriguez-Galindo C 2008 Second cancers in patients with the Ewing sarcoma family of tumours Eur. J. Cancer 44 983-91
30. NCRP 2012 Second primary cancers and cardiovascular disease after radiation therapy National Council on Radiation Protection and Measurements Report 170
31. Neglia J P, Friedman D L, Yasui Y, Mertens A C, Hammond S, Stovall M, Donaldson S S, Meadows A T and Robison L L 2001 Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study J. Natl Cancer Inst. 93 618-29
32. Neglia J P et al 2006 New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood cancer survivor study J. Natl Cancer Inst. 98 1528-37
33. Paganetti H, Niemierko A, Ancukiewicz M, Gerweck L E, Loeffler J S, Goitein M and Suit H D 2002 Relative biological effectiveness (RBE) values for proton beam therapy Int. J. Radiat. Oncol. Biol. Phys. 53 407-21
34. Paulussen M et al 2001 Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study Ann. Oncol. 12 1619-30
35. Preston D L, Pierce D A, Shimizu Y, Cullings H M, Fujita S, Funamoto S and Kodama K 2004 Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates Radiat. Res. 162 377-89
36. Rombi B et al 2012 Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes Int. J. Radiat. Oncol. Biol. Phys. 82 1142-8
37. Ron E 2006 Childhood cancer - treatment at a cost J. Natl Cancer Inst. 98 1510-1
38. Ron E, Lubin J H, Shore R E, Mabuchi K, Modan B, Pottern L M, Schneider A B, Tucker M A and Boice J D Jr 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies Radiat. Res. 141 259-77
39. Ronckers C M et al 2006 Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers Radiat. Res. 166 618-28
40. Sachs R K and Brenner D J 2005 Solid tumor risks after high doses of ionizing radiation Proc. Natl Acad. Sci. USA 102 13040-5
41. Sachs R K, Shuryak I, Brenner D, Fakir H, Hlatky L and Hahnfeldt P 2007 Second cancers after fractionated radiotherapy: stochastic population dynamics effects J. Theor. Biol. 249 518-31
42. Schneider U 2009 Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula Med. Phys. 36 1138-43
43. Schneider U and Kaser-Hotz B 2005a A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy Z. Med. Phys. 15 31-7
44. Schneider U and Kaser-Hotz B 2005b Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships Radiat. Environ. Biophys. 44 235-9
45. Schneider U, Lomax A, Besserer J, Pemler P, Lombriser N and Kaser-Hotz B 2007 The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 68 892-7
46. Schneider U, Lomax A and Timmermann B 2008 Second cancers in children treated with modern radiotherapy techniques Radiother. Oncol. 89 135-40
47. Schneider U, Sumila M and Robotka J 2011 Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy Theor. Biol. Med. Model. 8 27
48. Schneider U and Walsh L 2008 Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy Radiat. Environ. Biophys. 47 253-63
49. Schneider U, Zwahlen D, Ross D and Kaser-Hotz B 2005 Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose Int. J. Radiat. Oncol. Biol. Phys. 61 1510-5
50. Shore R E 1992 Issues and epidemiological evidence regarding radiation-induced thyroid cancer Radiat. Res. 131 98-111
51. Shuryak I, Hahnfeldt P, Hlatky L, Sachs R K and Brenner D J 2009a A new view of radiation-induced cancer: integrating short- and long-term processes: part I. Approach Radiat. Environ. Biophys. 48 263-74
52. Shuryak I, Hahnfeldt P, Hlatky L, Sachs R K and Brenner D J 2009b A new view of radiation-induced cancer: integrating short- and long-term processes: part II. Second cancer risk estimation Radiat. Environ. Biophys. 48 275-86
53. Sigurdson A J et al 2005 Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study Lancet 365 2014-23
54. Smith L M, Cox R S and Donaldson S S 1992 Second cancers in long-term survivors of Ewing's sarcoma Clin. Orthop. Relat. Res. 274 275-81
55. Steele G G and Wheldon T E 1991 Pediatric Oncology: Clinical Practice and Controversies ed P N Plowman and C R Pinkerton (London: Chapman and Hall)
56. Strong L C, Herson J, Osborne B M and Sutow W W 1979 Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma J. Natl Cancer Inst. 62 1401-6
57. Suit H, Goldberg S, Niemierko A, Ancukiewicz M, Hall E, Goitein M, Wong W and Paganetti H 2007 Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects Radiat. Res. 167 12-42
58. Sultan I, Rihani R, Hazin R and Rodriguez-Galindo C 2010 Second malignancies in patients with Ewing sarcoma family of tumors: a population-based study Acta Oncol. 49 237-44
59. Swerdlow A J, Barber J A, Vaughan Hudson G, Cunningham D, Gupta R K, Hancock B W, Horwich A, Lister T A and Linch D C 2000 Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment J. Clin. Oncol. 18 498-509
60. Wheldon E G, Lindsay K A and Wheldon T E 2000 The dose-response relationship for cancer incidence in a two-stage radiation carcinogenesis model incorporating cellular repopulation Int. J. Radiat. Biol. 76 699-710
61. Xu X G, Bednarz B and Paganetti H 2008 A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction Phys. Med. Biol. 53 R193-241
62. Zacharatou Jarlskog C, Lee C, Bolch W, Xu X G and Paganetti H 2008 Assessment of organ specific neutron doses in proton therapy using whole-body age-dependent voxel phantoms Phys. Med. Biol. 53 693-714
63. Zacharatou Jarlskog C and Paganetti H 2008 The risk of developing second cancer due to neutron dose in proton therapy as a function of field characteristics, organ, and patient age Int. J. Radiat. Oncol. Biol. Phys. 72 228-35